. . . . . . . "[Thus, we demonstrated antitumor activities of CP on ESCC, and as a biased agonist, CP induced ERK1/2 activation and receptor down-regulation required ?-arrestin1 and GRKs, suggesting a promising role for targeting IGF-1R in ESCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:38+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .